Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CERO will decline by -6.67% over the next 2 Weeks and hit $0.01 by Tuesday, August 4, 2026. In that time frame, CERO's share price is expected to range between $0.01 and $0.01.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 4, 2026 | 0.01 | 0.01 | 0.01 |
| Aug 3, 2026 | 0.01 | 0.01 | 0.01 |
| Jul 31, 2026 | 0.01 | 0.01 | 0.02 |
| Jul 30, 2026 | 0.01 | 0.01 | 0.01 |
| Jul 29, 2026 | 0.01 | 0.01 | 0.01 |
| Jul 28, 2026 | 0.01 | 0.01 | 0.01 |
| Jul 27, 2026 | 0.01 | 0.01 | 0.01 |
| Jul 24, 2026 | 0.01 | 0.01 | 0.02 |
| Jul 23, 2026 | 0.01 | 0.01 | 0.01 |
| Jul 22, 2026 | 0.01 | 0.01 | 0.01 |
CERO shares fell -16.67% in Wednesday, July 22, 2026's trading session, dropping from a previous close of $0.01 to move at $0.01. The stock demonstrated notable intraday movement (see CERO's key stats for a full breakdown), fluctuating between $0.01 and $0.01, a +20.00% trading range. While recent weeks have seen some volatility, CERO has managed to secure a -4.76% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 210.06K shares changing hands, 242.75K fewer than the previous session. This amounted to $2.10K in total market activity.
Will CERO Continue Its Upward Trend?
According to analyst ratings and projections for CERO, CERo Therapeutics Holdings, Inc. shares are anticipated to increase by +26.66%, potentially reaching $0.01 per share by August 4, 2026. Short-term technical indicators currently suggest a neutral sentiment for CERO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the CERO stock forecast, now is a good time to buy CERO stock because its current trading price is -10.71% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CERO covering social and institutional perspectives.
CERO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CERO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 42.60% to 44.22%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 35.94%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 33.96%, signals a bearish bias in the long-term trend. Insights into CERO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
CERo Therapeutics Short-Term Forecasts
CERO Forecast For Next 5 Days
Our algorithm anticipates CERo Therapeutics (CERO) stock could hit $0.01 by Jul 29, 2026. This represents a -2.00% fall from today's price, following a -95.24% change over the past five days.
CERO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for CERo Therapeutics Holdings, Inc. (CERO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.01, which would mean a 0 decrease from the current price of $0.01. Projections for this period range from a high of $0.01 to a low of $0.00.
CERO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for CERo Therapeutics's price over the next three months point to a drop. CERO stock is expected to peak at $165.19 on Sep 11, 2026 before potentially dipping to $0.00 on Oct 22, 2026. On average, CERO is likely to trade around $0.00 in the coming 90 days.
CERo Therapeutics Stock Forecast 2025
Based on our predictive models, CERo Therapeutics (CERO) is expected to trade between $0.00 and $188.64 throughout 2026. This would result in an average price of $0.00, potentially offering investors a -100.00% return from current levels.
CERo Therapeutics Holdings, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, CERo Therapeutics Holdings, Inc. (CERO) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $156.41, settling at an average of $0.00. This could translate to a -100.00% loss.
August 2026
Based on current market signals, CERo Therapeutics Holdings, Inc. is projected to trend august 2026. We forecast a trading range from $0.00 to $151.90, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
September 2026
Our predictive algorithms indicate CERo Therapeutics Holdings, Inc. stock may see a shift in September 2026. The expected range spans $0.00–$165.19, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
October 2026
Analyzing established trends, CERo Therapeutics Holdings, Inc. looks set to move in October 2026. Projections place the stock between $0.00 and $150.57, averaging around $0.00. This suggests a -100.00% loss from current levels.
November 2026
Market indicators suggest CERo Therapeutics Holdings, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $162.57, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
December 2026
Forecasting for December 2026, models estimate that CERo Therapeutics Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $188.64, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
January 2027
According to our latest forecast models, CERo Therapeutics Holdings, Inc. (CERO) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $166.48, settling at an average of $0.00. This could translate to a -100.00% loss.
February 2027
Based on current market signals, CERo Therapeutics Holdings, Inc. is projected to trend february 2027. We forecast a trading range from $0.00 to $152.97, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
March 2027
Our predictive algorithms indicate CERo Therapeutics Holdings, Inc. stock may see a shift in March 2027. The expected range spans $0.00–$171.51, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
April 2027
Analyzing established trends, CERo Therapeutics Holdings, Inc. looks set to move in April 2027. Projections place the stock between $0.00 and $177.22, averaging around $0.00. This suggests a -100.00% loss from current levels.
May 2027
Market indicators suggest CERo Therapeutics Holdings, Inc. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $158.77, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
June 2027
Forecasting for June 2027, models estimate that CERo Therapeutics Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $167.09, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
July 2027
According to our latest forecast models, CERo Therapeutics Holdings, Inc. (CERO) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $165.74, settling at an average of $0.00. This could translate to a -100.00% loss.
CERO's history of dividends and stock splits also plays a role in long-term investor confidence.